105.10
Schlusskurs vom Vortag:
$111.11
Offen:
$111.09
24-Stunden-Volumen:
8,352
Relative Volume:
1.08
Marktkapitalisierung:
$88.29M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
-5.30%
1M Leistung:
-3.57%
6M Leistung:
+21.20%
1J Leistung:
+58.73%
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Company Profile
Firmenname
Proshares Ultra Nasdaq Biotechnology 2 X Shares
Sektor
Branche
Telefon
-
Adresse
-
Compare BIB vs VOO, IVV, SPY, VTI, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BIB
Proshares Ultra Nasdaq Biotechnology 2 X Shares
|
105.10 | 88.29M | 0 | 0 | 0 | 0.00 |
|
VOO
Vanguard S P 500 Etf
|
701.61 | 1.03T | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
766.67 | 879.75B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
763.25 | 806.09B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
374.07 | 688.96B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
709.80 | 474.71B | 0 | 0 | 0 | 0.00 |
Proshares Ultra Nasdaq Biotechnology 2 X Shares Aktie (BIB) Neueste Nachrichten
ETFs Investing in Personalis, Inc. Stocks - TradingView
ETFs Investing in Rocket Pharmaceuticals, Inc. Stocks - TradingView
ETFs Investing in Voyager Therapeutics, Inc. Stocks - tradingview.com
ETFs Investing in Tyra Bioscience, Inc Stocks - TradingView
ETFs Investing in Replimune Group, Inc. Stocks - TradingView
ProShares Ultra Nasdaq Biotechnology declares quarterly distribution of $0.082554 - TradingView
Proshares Ultra Bitcoin ETF (BITU) Stock Price, News, Quote & History - Yahoo! Finance Canada
NYSE Top Gainers Bullish on CryptoETF's on the Run - Investorideas.com
PMV Capital Advisers, LLC's ProShares Ultra S&P500 2x Shares(SSO) Holding History - GuruFocus
How ProShares Ultra QQQ Quietly Built $14.46 Billion in Assets Despite Warnings That Leveraged ETFs Destroy Long-Term Wealth - 24/7 Wall St.
Buy on the Dip Prospects: July 29 Edition - ETF Database
Novavax Inc (NVAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Design Therapeutics Inc (DSGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pyxis Oncology Inc (PYXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nuvalent Inc (NUVL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Allogene Therapeutics Inc (ALLO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Geron Corp (GERN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oruka Therapeutics Inc (ORKA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Onkure Therapeutics Inc (OKUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Maravai LifeSciences Holdings Inc (MRVI) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Alumis Inc (ALMS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
EFO Dividend: 1.55% Yield, $1.18/Share — History & Dates - GuruFocus
Evolus Inc (EOLS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Omeros Corp (OMER) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MaxCyte Inc (MXCT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Abcellera Biologics Inc (ABCL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avidity Biosciences Inc (RNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
UBR Dividend: 1.69% Yield, $0.51/Share — History & Dates - GuruFocus
Alpha Teknova Inc (TKNO) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Humacyte Inc (HUMA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
UYG Dividend: 9.20% Yield, $10.67/Share — History & Dates - GuruFocus
ProShares Launches First ETF Targeting 2x the Daily Returns of the Nasdaq-100 Equal Weighted Index - Yahoo Finance
SpaceX IPO fuels ETF interest as employee ownership gains traction - scanx.trade
UWM Dividend: 0.69% Yield, $0.53/Share — History & Dates - GuruFocus
Castagnola vs Efstathiou | Prediction Markets - Coinbase
High-Yield Prospects: July 15 Edition - ETF Database
SK Hynix Soars 19% as Leveraged ETFs Launch, Lifting Micron, SanDisk, Western Digital - Yahoo Finance
07/06/2026 ValuEngine Weekly Market Summary & Commentary - The Globe and Mail
07/06/2026 ValuEngine Weekly Market Summary & Commentary - The Globe and Mail
BIBProShares Ultra Nasdaq Biotechnology 2X Shares Volatility & Greeks - Finviz
UJB ETF | ProShares Ultra High Yield 2x Shares - GuruFocus
UJB ETF | ProShares Ultra High Yield 2x Shares - GuruFocus
Yesterday’s Tech Rout Shows How Leveraged ETFs Can Destroy Wealth - Yahoo Finance
Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar. - AOL.com
Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar. - AOL.com
Mersana Therapeutics Inc (MRSN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inozyme Pharma Inc (INZY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alnylam Pharmaceuticals Inc (ALNY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Finanzdaten der Proshares Ultra Nasdaq Biotechnology 2 X Shares-Aktie (BIB)
Es liegen keine Finanzdaten für Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):